Medicinal Products

Bunalict 8 mg/2 mg sublingvalne tablete

Name Bunalict 8 mg/2 mg sublingvalne tablete
Marketing Authorisation Number HR-H-324019251
Active Substance buprenorfinklorid
naloksonklorid dihidrat
Composition svaka sublingvalna tableta sadrži 8 mg buprenorfina (u obliku klorida) i 2 mg naloksona (u obliku klorid dihidrata)
Pharmaceutical Form sublingvalna tableta
Manufacturer Ethypharm, Le Grand Quevilly, Francuska
Ethypharm, Chateauneuf-en-Thymerais, Francuska
Salutas Pharma GmbH, Barleben, Njemačka
Marketing Authorisation Holder Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska
Marketing Authorisation Date 24.11.2022
MA Period of Validity unlimited
Classification Number UP/I-530-09/22-02/83
Registration Number 381-12-01/154-22-02
Prescription Medicinal product subject to medical prescription
Type of prescription poseban recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N07BC51
Marketing status trajni prekid opskrbe
SmPC download
PL download
Public Assessment Report download

Packaging

Back